Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

Published Date: 13 Dec 2024

Benefit seen in all prespecified subgroups, including high-risk patients

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI tool identifies women at high risk of interval breast cancer

2.

An Eye Surgeon's Unexpected Discovery of the "Before and After".

3.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

4.

Chronic pain and poor sleep are troublesome bed partners.

5.

Childhood cancer survivors face new health problems later in life, study shows


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot